Tuesday, Feb 13, 2001
South San Francisco, Calif. -- February 13, 2001 --
SOUTH SAN FRANCISCO, Calif. -- February 13, 2001 -- Genentech, Inc. (NYSE: DNA) will be providing a live webcast of a meeting at which senior officers of the company will review the company's strategy, pipeline and commercial products. Genentech invites investors and the general public to listen to this webcast on February 21, 2001 at 9:00 am Eastern Time.
The webcast can be accessed by going to Genentech's website at http://www.gene.com and will be archived and available for replay through the close of business on February 28, 2001.
Genentech, Inc. is a leading biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals for significant unmet medical needs. Fourteen of the currently approved biotechnology products stem from Genentech science. Genentech markets nine biotechnology products directly in the United States. The company has headquarters in South San Francisco, California and is traded on the New York Stock Exchange under the symbol DNA.
# # #